SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-203837
Filing Date
2023-08-04
Accepted
2023-08-04 16:02:45
Documents
13
Period of Report
2023-07-31
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d543614d8k.htm   iXBRL 8-K 26543
  Complete submission text file 0001193125-23-203837.txt   189877

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eftr-20230731.xsd EX-101.SCH 4334
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eftr-20230731_def.xml EX-101.DEF 14094
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE eftr-20230731_lab.xml EX-101.LAB 23583
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eftr-20230731_pre.xml EX-101.PRE 15127
7 EXTRACTED XBRL INSTANCE DOCUMENT d543614d8k_htm.xml XML 5583
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39866 | Film No.: 231143937
SIC: 2834 Pharmaceutical Preparations